Arkolith/Insider Trading/EKSO/Form 4

Glenn John

Chief Financial OfficerEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Mar 28, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 22, 2022Sell(S)3K$2.82$10K35K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-021330) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML